Watch Dennis Slamon, M.D., Ph.D., director of clinical/translational research for the University of California, Los Angeles (UCLA) Revlon Womens Cancer Research Program at UCLAs Jonsson Comprehensive Cancer Center. He is also a Stand Up To Cancer Dream Team Leader. Dr. Slamon presented updated results of his groundbreaking work with trastuzumab, currently sold as Herceptin by Genetech-Roche.
Link to this comment:
All Comments (0)